U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 20-26, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 20-26, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/20/2024
Location: Las Vegas, NV
Subject: HLTH 2024 Welcome Reception
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and media

Event Date: 10/21/2024
Location: Virtual
Subject: FDA and NIH Joint Public Meeting on Advancing Tobacco Cessation: FDA and NIH Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other registered attendees

Event Date: 10/21/2024
Location: Las Vegas, NV
Subject: HLTH 2024; Speaker: A Conversation with Dr. Robert M. Califf
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/22/2024
Location: Washington, DC
Subject: 2024 National Organization for Rare Disorders Summit; Speaker: Fireside Chat
FDA Participant/Group: HILARY MARSTON; IBILOLA FASHOYIN-AJE; ROSA SHERAFAT-KAZEMZADEH; ANDREA FURIA-HELMS; KIMBERLY SMITH; CATHERINE PILGRIM-GRAYSON;
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/23/2024
Location: Bethesda, MD
Subject: 2024 Generics and Biosimilars (GRx+Biosims) Conference; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered attendees

Event Date: 10/23/2024
Location: Virtual
Subject: Oncology Center of Excellence Virtual Public Panel: Pazdur Silver FDA Anniversary
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Mark McClellan (Duke-Margolis Institute for Health Policy); Andrew Von Eschenbach (Bipartisan Policy Center); Margaret Hamburg (American Association for the Advancement of Science); Scott Gottlieb (American Enterprise Institute);

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/21/2024
Location: Arlington, VA
Subject: Food Safety Consortium; Speaker: Human Foods Program Update
FDA Participant/Group: DOUGLAS STEARN;
Non FDA Participant/Group: Foods industry, trade associations, academia, and government

Event Date: 10/21/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Gerald Kunde, Jean-Pierre Punsola, Monique Pellegrino (Ferrero);

Event Date: 10/22/2024
Location: Las Vegas, NV
Subject: HLTH 2024; Fireside Chat: Nutrition at Your Fingertips
FDA Participant/Group: N/A
Non FDA Participant/Group: Foods industry, trade associations, academia, and government

Event Date: 10/24/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Safe Food Coalition representing consumer, public health, research, and labor organizations

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

Event Date: 10/22/2024
Location: Rockville, MD
Subject: 2024 Generics and Biosimilars (GRx+Biosims) Conference; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, media, and other registered attendees

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/21/2024
Location: Washington, DC
Subject: 2024 National Organization for Rare Disorders Summit; Panelist: Embracing Innovation to Enhance Clinical Trial Success
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/24/2024
Location: Washington, DC
Subject: BIO Patient and Health Advocacy Summit; Lunch Fireside Chat: What's New? FDA's Rare Disease Innovation Hub
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Representatives from patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/21/2024
Location: Virtual
Subject: Integrated Continuous Biomanufacturing VI: An Engineering Conferences International Conference Series; Speaker: Efforts at FDA to Facilitate Advanced Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, media, and other stakeholders

Event Date: 10/21/2024
Location: Washington, DC
Subject: 2024 National Organization for Rare Disorders Summit; Speaker: Can We Make Gene Therapy More Accessible
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/23/2024
Location: New York City, NY
Subject: Young and Partners Pharmaceutical Executive Summit, 2024: Brave New World - Where Are We Heading? Speaker: The Future of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, media, and other stakeholders

Event Date: 10/24/2024
Location: Virtual
Subject: 2024 International Biomedical Industry Innovation Conference, Beijing Forum; Speaker: The Future of Cell and Gene Therapy: An FDA Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, media, and other stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 10/20/2024
Location: Chicago, IL
Subject: American Academy of Ophthalmology Annual Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Academy of Ophthalmology

Event Date: 10/21/2024
Location: Washington, DC
Subject: 2024 National Organization for Rare Disorders Summit; Speaker: The Growing Role of Medical Devices
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/24/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: DANIEL CANOS; REBECCA TORGUSON; NATASHA THORNE; BRITTANY SCHUCK;
Non FDA Participant/Group: Several leadership representatives of The Mitre Corporation

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/22/2024
Location: Virtual
Subject: Electronic Nicotine Delivery System (ENDS) Enforcement Briefing
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff members from the office of Senator Martin Heinrich (D-NM)

Event Date: 10/24/2024
Location: Washington, DC
Subject: Food and Drug Law Institute (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 10/23/2024
Location: Rockville, MD
Subject: Alliance for a Stronger FDA Meeting
FDA Participant/Group: TIMOTHY SCHELL; MATTHEW LUCIA; ROXANNE SCHWEITZER; WILLIAM FLYNN;
Non FDA Participant/Group: Ginny Siller (American Health Institute); Kalkidane Yesuf (American Society for Microbiology); Eric Steiner, Phil Karsting (OFW Law); Thomas Seoh (Kilatys); Amar Bhat (Reagan-Udall Foundation for the FDA); Atalie Ebersole, Dana Brooks (Pet Food Institute (PFI)); Ron Bartek (Friedreich’s Ataxia Research Foundation); Caitlin Boon (Mars, Inc); Austin Therrell (American Association of Feed Control Officers); Steven Grossman (Alliance for a Stronger FDA);

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top